University of Helsinki-ko ikertzaileekin lankidetzan egindako argitalpenak (4)

2017

  1. Rapalogs can promote cancer cell stemness in vitro in a Galectin-1 and H-ras-dependent manner

    Oncotarget, Vol. 8, Núm. 27, pp. 44550-44566

2016

  1. Cancer stem cell drugs target K-ras signaling in a stemness context

    Oncogene, Vol. 35, Núm. 40, pp. 5248-5262

2015

  1. Phenotypic Screening Identifies Protein Synthesis Inhibitors as H-Ras-Nanocluster-Increasing Tumor Growth Inducers

    Biochemistry, Vol. 54, Núm. 49, pp. 7212-7221

  2. Specific cancer-associated mutations in the switch III region of ras increase tumorigenicity by nanocluster augmentation

    eLife, Vol. 4, Núm. AUGUST2015, pp. 1-23